{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:58:28Z","timestamp":1792735108927,"version":"4.5.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1212\/wnl.50.1.41","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:31:39Z","timestamp":1336915899000},"page":"41-46","source":"Crossref","is-referenced-by-count":87,"title":["Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies"],"prefix":"10.1212","volume":"50","author":[{"given":"Simone","family":"Spuler","sequence":"first","affiliation":[{"name":"From the Department of Neurology, Neuromuscular Laboratory, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Engel","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Neuromuscular Laboratory, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"3","volume":"314","year":"1986","unstructured":"Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986;314:331-334.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270103"},{"key":"e_1_3_1_4_2","first-page":"2","volume":"16","year":"1984","unstructured":"Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984;16:209-215.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_5_2","unstructured":"Engel AG Arahata K Emslie-Smith AM. Immune effector mechanisms in inflammatory myopathies. In: Waksman BH ed. Immunologic mechanisms in neurologic and psychiatric disease. New York: Raven Press 1990:141-160."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(87)90179-1"},{"key":"e_1_3_1_7_2","first-page":"4","volume":"37","year":"1995","unstructured":"Al-Lozi MT, Pestronk A, Yee WC, Flaris N. Myopathy and paraproteinemia with serum IgM binding to a high-molecular-weight muscle fiber surface protein. Ann Neurol 1995;37:41-46.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_8_2","first-page":"4","volume":"344","year":"1996","unstructured":"Al-Lozi MT, Pestronk A. Myopathies with serum IgM binding to the BJ antigen and IgM deposition in muscle endomysium. Neurology 1996;A344:46.","journal-title":"Neurology"},{"key":"e_1_3_1_9_2","first-page":"6","volume":"37","year":"1995","unstructured":"Villanova M, Louboutin J-P, Chateau D, et al. X-linked vacuolated myopathy: complement membrane attack complex on surface membrane of injured muscle fibers. Ann Neurol 1995;37:637-645.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410102"},{"key":"e_1_3_1_11_2","unstructured":"Liszewski MK Atkinson JP. The complement system. In: Paul W ed. Fundamental immunology. 3rd ed. New York: Raven Press 1993;917-940."},{"key":"e_1_3_1_12_2","first-page":"4","volume":"44","year":"1994","unstructured":"Tawil R, McDermott MP, Mendell JR, Kissel JT, Griggs RC, FSH-DY Group. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. Neurology 1994;44:442-446.","journal-title":"Neurology"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.6_Suppl_8.S3"},{"key":"e_1_3_1_14_2","first-page":"3","volume":"12","year":"1982","unstructured":"Wulff JD, Lin JT, Kepes JJ. Inflammatory facioscapulohumeral muscular dystrophy and Coats syndrome. Ann Neurol 1982;12:398-401.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_15_2","first-page":"2","volume":"110","year":"1984","unstructured":"Meyerson MD, Lewis E, Ill K. Facioscapulohumeral dystrophy and accompanying hearing loss. Acta Otolaryngol 1984;110:261-266.","journal-title":"Acta Otolaryngol"},{"key":"e_1_3_1_16_2","unstructured":"Shields RW Jr. Limb girdle syndromes. In: Engel AG Franzini-Armstrong C eds. Myology. 2nd ed. New York: McGraw-Hill 1994:1258-1274."},{"key":"e_1_3_1_17_2","unstructured":"Engel AG. The muscle biopsy. In: Engel AG Franzini-Armstrong C eds. Myology. 2nd ed. New York: McGraw-Hill 1994:822-831."},{"key":"e_1_3_1_18_2","first-page":"4","volume":"28","year":"1978","unstructured":"Bodensteiner JB, Engel AG. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 1978;28:439-446.","journal-title":"Neurology"},{"key":"e_1_3_1_19_2","first-page":"3","volume":"15","year":"1994","unstructured":"Morgan BP, Meri S. Membrane proteins that protect against complement lysis. Springer Semin Immunopathol 1994;15:369-396.","journal-title":"Springer Semin Immunopathol"},{"key":"e_1_3_1_20_2","first-page":"3","volume":"144","year":"1990","unstructured":"Rollins SA, Sims PJ. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 1990;144:3478-3483.","journal-title":"J Immunol"},{"key":"e_1_3_1_21_2","first-page":"2","volume":"12","year":"1982","unstructured":"Engel AG, Biesecker G. Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers. Ann Neurol 1982;12:289-296.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410160102"},{"key":"e_1_3_1_23_2","first-page":"9","volume":"47","year":"1966","unstructured":"Brooke MH, Engel WK. The histologic diagnosis of neuromuscular diseases: review of 79 biopsies. Arch Phys Med Rehabil 1966;47:99-121.","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.22.5_Part_2.3"},{"key":"e_1_3_1_25_2","first-page":"2","volume":"231","year":"1985","unstructured":"Bacq M, Telerman-Toppet N, Coers C. Familiar myopathies with restricted distribution, facial weakness and inflammatory changes in affected muscles. J Neurol 1985;231:295-300.","journal-title":"J Neurol"},{"key":"e_1_3_1_26_2","first-page":"6","volume":"336","year":"1990","unstructured":"Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW. The facioscapulohumeral muscular dystrophy gene maps to chromosome 4. Lancet 1990;336:651-653.","journal-title":"Lancet"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91517-E"},{"key":"e_1_3_1_28_2","first-page":"2","volume":"5","year":"1995","unstructured":"Goto K, Lee JH, Matsuda C, et al. DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlations. Neuromuscul Disord 1995;5:201-208.","journal-title":"Neuromuscul Disord"},{"key":"e_1_3_1_29_2","first-page":"9","volume":"99","year":"1976","unstructured":"Bethlem J, Van Wijngaarden GK. Benign myopathy with autosomal dominant inheritance. Brain 1976;99:91-100.","journal-title":"Brain"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410200103"},{"key":"e_1_3_1_31_2","first-page":"2","volume":"83","year":"1991","unstructured":"Marconi G, Pizzi A, Arimondi CG, Vannelli B. Limb girdle muscular dystrophy with autosomal dominant inheritance. Acta Neurol Scand 1991;83:234-238.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390104"},{"key":"e_1_3_1_33_2","first-page":"1","volume":"50","year":"1992","unstructured":"Speer MC, Yamaoka LH, Gilchrist JH, et al. Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. Am J Hum Genet 1992;50:1211-1217.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_34_2","first-page":"3","volume":"156","year":"1996","unstructured":"Gasque P, Morgan BP, Legoedec J, Chan P, Fontaine M. Human skeletal myoblasts spontaneously activate allogenic complement but are resistant to killing. J Immunol 1996;156:3402-3411.","journal-title":"J Immunol"},{"key":"e_1_3_1_35_2","first-page":"9","volume":"20","year":"1997","unstructured":"Navenot J-M, Villanova M, Lucas-H\u00e9ron B, Malandrini A, Blanchard D, Louboutin J-P. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers. Muscle Nerve 1997;20:92-96.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_36_2","first-page":"5","volume":"75","year":"1978","unstructured":"Bhakdi,S, Tranum-Jensen J. Molecular nature of the complement lesion. Proc Natl Acad Sci USA 1978;75:5655-5659.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.50.1.41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:26:39Z","timestamp":1711639599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.50.1.41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1212\/WNL.50.1.41"],"URL":"https:\/\/doi.org\/10.1212\/wnl.50.1.41","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}